O H Ryu1, J C Atkinson, G T Hoehn, G G Illei, T C Hart. 1. Human Craniofacial Genetics Section, Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), Bethesda, MD 20892-1470, USA.
Abstract
OBJECTIVES: To identify the most significant salivary biomarkers in Sjögren's syndrome (SS) using proteomic methods. METHODS: Parotid saliva from 20 non-SS subjects and 41 primary SS patients was analysed. Protein expression profiles for each sample were generated by surface-enhanced laser desorption/ionization time-of-flight-mass spectrometry (SELDI-TOF-MS). Mean peak intensities of SS patients and non-SS subjects were compared by univariate analyses. Samples pooled by diagnosis (SS and non-SS) and labelled with different Cy dyes were compared by two-dimensional difference gel electrophoresis (2D-DIGE). Two protein levels that were most significantly different by SELDI-TOF-MS and 2D-DIGE were validated by enzyme-linked immunosorbent assay in individual samples. RESULTS: SELDI-TOF-MS of 10-200 kDa peaks revealed eight peaks with >2-fold changes in the SS group that differed from non-SS at P < 0.005. Peaks of 11.8, 12.0, 14.3, 80.6 and 83.7 kDa were increased, while 17.3, 25.4, and 35.4 kDa peaks were decreased in SS samples. 2D-DIGE identified significant increases of beta-2-microglobulin, lactoferrin, immunoglobulin (Ig) kappa light chain, polymeric Ig receptor, lysozyme C and cystatin C in all stages of SS. Two presumed proline-rich proteins, amylase and carbonic anhydrase VI, were reduced in the patient group. Three of these ten biomarkers have not been associated previously with SS. CONCLUSIONS: The salivary proteomic profile of SS is a mixture of increased inflammatory proteins and decreased acinar proteins when compared with non-SS. Future studies will test the ability of these biomarker levels, alone and in combination, to diagnose the salivary component of SS.
OBJECTIVES: To identify the most significant salivary biomarkers in Sjögren's syndrome (SS) using proteomic methods. METHODS: Parotid saliva from 20 non-SS subjects and 41 primary SS patients was analysed. Protein expression profiles for each sample were generated by surface-enhanced laser desorption/ionization time-of-flight-mass spectrometry (SELDI-TOF-MS). Mean peak intensities of SS patients and non-SS subjects were compared by univariate analyses. Samples pooled by diagnosis (SS and non-SS) and labelled with different Cy dyes were compared by two-dimensional difference gel electrophoresis (2D-DIGE). Two protein levels that were most significantly different by SELDI-TOF-MS and 2D-DIGE were validated by enzyme-linked immunosorbent assay in individual samples. RESULTS: SELDI-TOF-MS of 10-200 kDa peaks revealed eight peaks with >2-fold changes in the SS group that differed from non-SS at P < 0.005. Peaks of 11.8, 12.0, 14.3, 80.6 and 83.7 kDa were increased, while 17.3, 25.4, and 35.4 kDa peaks were decreased in SS samples. 2D-DIGE identified significant increases of beta-2-microglobulin, lactoferrin, immunoglobulin (Ig) kappa light chain, polymeric Ig receptor, lysozyme C and cystatin C in all stages of SS. Two presumed proline-rich proteins, amylase and carbonic anhydrase VI, were reduced in the patient group. Three of these ten biomarkers have not been associated previously with SS. CONCLUSIONS: The salivary proteomic profile of SS is a mixture of increased inflammatory proteins and decreased acinar proteins when compared with non-SS. Future studies will test the ability of these biomarker levels, alone and in combination, to diagnose the salivary component of SS.
Authors: Mireya Gonzalez-Begne; Bingwen Lu; Lujian Liao; Tao Xu; Gurrinder Bedi; James E Melvin; John R Yates Journal: J Proteome Res Date: 2011-10-13 Impact factor: 4.466
Authors: Daniel Kagedan; Irene Lecker; Ihor Batruch; Christopher Smith; Ilia Kaploun; Kirk Lo; Ethan Grober; Eleftherios P Diamandis; Keith A Jarvi Journal: Clin Proteomics Date: 2012-02-06 Impact factor: 3.988
Authors: Prasanna Ramachandran; Pinmanee Boontheung; Eric Pang; Weihong Yan; David T Wong; Joseph A Loo Journal: Clin Proteomics Date: 2008-12 Impact factor: 3.988
Authors: Chih-Ko Yeh; Nicolaos J Christodoulides; Pierre N Floriano; Craig S Miller; Jeffrey L Ebersole; Shannon E Weigum; John McDevitt; Spencer W Redding Journal: Tex Dent J Date: 2010-07
Authors: Leonard Moore; Zorabel M LeJeune; Candace A Luces; Arther T Gates; Min Li; Bilal El-Zahab; Jayne C Garno; Isiah M Warner Journal: Anal Chem Date: 2010-05-15 Impact factor: 6.986
Authors: Matin M Imanguli; Jane C Atkinson; Kristen E Harvey; Gerard T Hoehn; Ok Hee Ryu; Tianxia Wu; Albert Kingman; A John Barrett; Michael R Bishop; Richard W Childs; Daniel H Fowler; Steven Z Pavletic; Thomas C Hart Journal: Exp Hematol Date: 2007-02 Impact factor: 3.084
Authors: Máire E Doyle; Lori Boggs; Robert Attia; Lauren R Cooper; Daniel R Saban; Cuong Q Nguyen; Ammon B Peck Journal: Am J Pathol Date: 2007-09-06 Impact factor: 4.307